Since DREAM serves as a Ca2+-sensor transcription factor in neurons, it can also participate in the progression of several neurodegenerative disorders, including Alzheimer’s (AD) and Huntington’s (HD) disease, and amyotrophic lateral sclerosis (ALS). Here, KCNIP3 is linked to Alzheimer disease.